Luther King Capital Management (LKCM)’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.7M Sell
232,579
-9,441
-4% -$629K 0.06% 152
2026
Q1
$15.2M Buy
242,020
+40,966
+20% +$2.85M 0.07% 146
2025
Q4
$13.3M Sell
201,054
-31,529
-14% -$2.04M 0.05% 155
2025
Q3
$15.7M Sell
232,583
-27,410
-11% -$2.17M 0.06% 144
2025
Q2
$22.7M Buy
259,993
+17,343
+7% +$1.36M 0.1% 128
2025
Q1
$16.6M Buy
242,650
+20,518
+9% +$1.67M 0.08% 136
2024
Q4
$17.3M Buy
222,132
+8,887
+4% +$658K 0.07% 136
2024
Q3
$14.3M Buy
213,245
+56,365
+36% +$4.63M 0.06% 137
2024
Q2
$17.8M Buy
156,880
+11,013
+8% +$1.39M 0.08% 130
2024
Q1
$20.2M Buy
145,867
+29,714
+26% +$3.74M 0.09% 124
2023
Q4
$14.4M Buy
116,153
+70,433
+154% +$7.2M 0.07% 138
2023
Q3
$4.27M Buy
45,720
+58
+0.1% +$6.54K 0.02% 215
2023
Q2
$5.87M Buy
45,662
+2
+0% +$242 0.03% 190
2023
Q1
$5.3M Sell
45,660
-45
-0.1% -$5.04K 0.03% 188
2022
Q4
$5.18M Buy
45,705
+45
+0.1% +$4.94K 0.03% 179
2022
Q3
$3.68M Sell
45,660
-40
-0.1% -$3.39K 0.02% 212
2022
Q2
$3.41M Sell
45,700
-228
-0.5% -$20.8K 0.02% 227
2022
Q1
$5.87M Buy
45,928
+42,996
+1,466% +$4.7M 0.03% 182
2021
Q4
$394K Buy
2,932
+12
+0.4% +$1.72K ﹤0.01% 522
2021
Q3
$399K Buy
+2,920
New +$368K ﹤0.01% 516
2018
Q1
Sell
-54,700
Closed -$785K 523
2017
Q4
$785K Sell
54,700
-2,880
-5% -$37.4K 0.01% 384
2017
Q3
$704K Sell
57,580
-160
-0.3% -$2.83K 0.01% 381
2017
Q2
$1.06M Buy
57,740
+9,320
+19% +$172K 0.01% 340
2017
Q1
$1.03M Buy
48,420
+360
+0.7% +$7.03K 0.01% 342
2016
Q4
$717K Sell
48,060
-20,320
-30% -$360K 0.01% 376
2016
Q3
$1.5M Sell
68,380
-10,900
-14% -$243K 0.01% 311
2016
Q2
$1.57M Sell
79,280
-107,820
-58% -$1.84M 0.02% 311
2016
Q1
$3.18M Sell
187,100
-328,300
-64% -$5.48M 0.03% 262
2015
Q4
$10.6M Sell
515,400
-123,500
-19% -$2.57M 0.1% 187
2015
Q3
$13.7M Sell
638,900
-103,020
-14% -$2.3M 0.13% 165
2015
Q2
$14.8M Sell
741,920
-2,209,800
-75% -$38.8M 0.13% 175
2015
Q1
$46M Sell
2,951,720
-840,276
-22% -$12.7M 0.39% 72
2014
Q4
$52.2M Sell
3,791,996
-358,724
-9% -$4.39M 0.42% 67
2014
Q3
$41.5M Buy
4,150,720
+198,760
+5% +$2.03M 0.34% 80
2014
Q2
$39.2M Buy
3,951,960
+298,720
+8% +$2.65M 0.31% 93
2014
Q1
$37.8M Sell
3,653,240
-880,800
-19% -$9.1M 0.31% 99
2013
Q4
$40.1M Sell
4,534,040
-159,920
-3% -$1.27M 0.32% 102
2013
Q3
$33.1M Sell
4,693,960
-1,120,840
-19% -$7.1M 0.28% 120
2013
Q2
$32.6M Buy
+5,814,800
New +$27.9M 0.3% 108

Other funds holding DXCM

Luther King Capital Management (LKCM)'s DXCM Position: Q2 2026 in Review

Luther King Capital Management (LKCM) reduced its DexCom (DXCM) stake by 3.9% in Q2 2026, selling an estimated $629K and leaving 232,579 shares worth $15.7M. The position accounts for 0.06% of the portfolio, ranked #152.

Luther King Capital Management (LKCM) first reported a position in DXCM in Q2 2013 and has held it in 39 quarters since. The position peaked at $52.2M in Q4 2014. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Luther King Capital Management (LKCM) held 232,579 shares of DexCom worth $15.7M as of Q2 2026.
  • Luther King Capital Management (LKCM) sold 9,441 DexCom shares in Q2 2026, an estimated $629K.
  • DexCom made up 0.06% of Luther King Capital Management (LKCM)'s portfolio in Q2 2026, its #152 holding.
  • Luther King Capital Management (LKCM) first reported a position in DexCom in Q2 2013 and has held it in 39 quarters since.
  • Luther King Capital Management (LKCM)'s DexCom position peaked at $52.2M in Q4 2014.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q2 2026, filed 10 Aug 2026.